A recommendation for the 2018 flu vaccine will be made in September 2017. Each September, in the Southern Hemisphere, The WHO convenes technical consultations to recommend viruses for inclusion in influenza vaccines.
The below information is for the 2017 flu vaccination season:
The committee recommended that the TGA should adopt the September 2016 WHO recommendations;
The Trivalent influenza vaccine components for the Australian 2017 influenza season should contain the following:
- A (H1N1): an A/Michigan/45/2015 (H1N1)pdm09 like virus
- A (H3N2): an A/Hong Kong/4801/2014 (H3N2) like virus
- B: a B/Brisbane/60/2008 like virus
It is recommended that Quadrivalent influenza vaccines containing two influenza B viruses contain the above three viruses and a B/Phuket/3073/2013-like virus.
The AIVC recommendation for the composition of influenza vaccines for Australia in 2017 introduces a new A (H1N1) pdm09 like virus strain when compared to the composition of the Trivalent and Quadrivalent vaccines for Australia in 2016.
Corporate Care offers workplace flu vaccination programs. Please call 1300 79 74 10 for further information. Alternatively please complete the web form so we can get in touch with you.